Pharm.D | Pharmacist
Gerardo Sison, Pharm.D. is a pharmacist with experience in both clinical and retail settings, where he has counseled both patients and healthcare providers on medication management and drug information. He has almost a decade of experience as a medical writer and reviewer for various medical and health organizations, including RxSense and BetterHelp. Gerardo currently specializes in evidence-based writing on diabetes care and weight management to help readers make the right decisions about medications and other treatment options. He is a member of the American Medical Writers Association (AMWA).
TL;DR Managing weight isn’t just a cosmetic concern. It’s often a key part of controlling blood pressure or cholesterol levels and improving other health outcomes. However, diet and lifestyle changes aren’t always enough. Medications that mimic the GLP-1 hormone can be effective for weight loss and related conditions such as diabetes. Zepbound is a newer … Read more
TL;DR Treatment options have expanded over the years when it comes to type 2 diabetes. GLP-1 medications are some of the newest drugs, approved for managing blood sugar levels and weight loss. Medications like Monunjaro go one step further in targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1), two key hormones involved in … Read more
With clinical trial results showing an average weight loss of over 20% for many people, there’s no question that tirzepatide is an effective drug. Under the brand names Mounjaro® (for type 2 diabetes) and Zepbound® (for obesity and sleep apnea), it’s now one of the most in-demand GLP-1/GIP medications on the market. However, it’s also one of … Read more
GLP-1 (glucagon-like peptide-1) drugs are continuing to become household names for weight loss. They activate a receptor that has potential effects extending beyond just managing weight, with benefits on blood sugar levels, as well as heart, kidney, and liver health. One of the newest approved options is tirzepatide. However, unlike GLP-1 drugs like semaglutide and … Read more